Soluble forms of Hendra and Nipah virus G glycoprotein
View Patent ↗This invention relates to soluble forms of G glycoprotein from Hendra and Nipah virus. In particular, this invention relates to compositions comprising soluble forms of G glycoprotein from Hendra and Nipah virus and also to diagnostic and therapeutic methods using the soluble forms of G glycoprotein from Hendra and Nipah virus. Further, the invention relates to therapeutic antibodies including neutralizing antibodies, and vaccines for the prevention and treatment of infection by Hendra and Nipah viruses.
1. An isolated oligomeric peptide wherein the monomers of the oligomeric peptide consist of the ectodomain of the Hendra virus G protein with an amino acid sequence of SEQ ID NO: 16.
2. The isolated oligomeric peptide of claim 1 , which retains one or more characteristics of a native Hendra virus G protein.
3. The isolated oligomeric peptide of claim 2 , wherein the one or more characteristics are selected from the group consisting of ability to interact with a viral host receptor cell, ability to elicit an antibody reaction, ability to elicit a neutralizing antibody reaction, ability to block or prevent infection of a host cell by Hendra virus, and combinations thereof.
4. The isolated oligomeric peptide of claim 1 , wherein the oligomeric peptide is a dimer.
5. A pharmaceutical composition comprising the isolated oligomeric peptide of claim 4 and a pharmaceutically acceptable carrier.
6. The isolated oligomeric peptide of claim 1 , wherein the oligomeric peptide is a tetramer.
7. A pharmaceutical composition comprising the isolated oligomeric peptide of claim 1 and a pharmaceutically acceptable carrier.
8. A fusion protein containing the oligomeric peptide of claim 1 linked to another peptide.
9. The fusion protein of claim 8 , wherein the another peptide is derived from vaccinia virus.